Yuichiro Doki

446 total citations
42 papers, 236 citations indexed

About

Yuichiro Doki is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yuichiro Doki has authored 42 papers receiving a total of 236 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Surgery, 12 papers in Pulmonary and Respiratory Medicine and 12 papers in Oncology. Recurrent topics in Yuichiro Doki's work include Pancreatic and Hepatic Oncology Research (5 papers), Gastric Cancer Management and Outcomes (5 papers) and Esophageal and GI Pathology (5 papers). Yuichiro Doki is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Gastric Cancer Management and Outcomes (5 papers) and Esophageal and GI Pathology (5 papers). Yuichiro Doki collaborates with scholars based in Japan, Germany and China. Yuichiro Doki's co-authors include Yoshiyuki Fujiwara, Masahiko Yano, Takushi Yasuda, Isao Miyashiro, Makoto Yamasaki, Hiroshi Miyata, Ko Takachi, Yo Sasaki, Hiroaki Ohigashi and Hideo Nakajima and has published in prestigious journals such as Scientific Reports, Carcinogenesis and Annals of Surgical Oncology.

In The Last Decade

Yuichiro Doki

28 papers receiving 234 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuichiro Doki Japan 9 125 76 52 43 27 42 236
Eugeniusz Wróblewski Poland 9 184 1.5× 50 0.7× 23 0.4× 29 0.7× 43 1.6× 27 234
Marek Winiarski Poland 13 200 1.6× 68 0.9× 83 1.6× 35 0.8× 37 1.4× 28 358
H N Nguyen Germany 13 300 2.4× 63 0.8× 53 1.0× 24 0.6× 70 2.6× 22 483
Sabrina Mellino Italy 8 26 0.2× 138 1.8× 83 1.6× 54 1.3× 46 1.7× 14 295
Yu‐Wen Hsu Taiwan 9 82 0.7× 92 1.2× 26 0.5× 70 1.6× 76 2.8× 14 377
Tomoe Kawamura Japan 9 102 0.8× 46 0.6× 93 1.8× 84 2.0× 234 8.7× 20 404
Yuko Shibuya Japan 10 46 0.4× 28 0.4× 16 0.3× 16 0.4× 22 0.8× 23 239
A Grisendi Italy 10 246 2.0× 48 0.6× 33 0.6× 18 0.4× 148 5.5× 19 434
Miguel Quesada‐Charneco Spain 8 66 0.5× 29 0.4× 55 1.1× 20 0.5× 28 1.0× 18 283
Wenmao Yan China 12 241 1.9× 83 1.1× 61 1.2× 100 2.3× 16 0.6× 23 327

Countries citing papers authored by Yuichiro Doki

Since Specialization
Citations

This map shows the geographic impact of Yuichiro Doki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuichiro Doki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuichiro Doki more than expected).

Fields of papers citing papers by Yuichiro Doki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuichiro Doki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuichiro Doki. The network helps show where Yuichiro Doki may publish in the future.

Co-authorship network of co-authors of Yuichiro Doki

This figure shows the co-authorship network connecting the top 25 collaborators of Yuichiro Doki. A scholar is included among the top collaborators of Yuichiro Doki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuichiro Doki. Yuichiro Doki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ikenaga, Naoki, Tsuyoshi Takahashi, Koji Tanaka, et al.. (2025). Overexpression of Transferrin Receptor in Esophageal Squamous Cell Cancer Suggests Poor Prognosis and Potential Therapy. Cancer Science. 117(2). 393–406.
2.
Yamada, Daisaku, Shogo Kobayashi, Hidenori Takahashi, et al.. (2025). Post hoc subgroup analysis of neoadjuvant gemcitabine plus S1 vs gemcitabine plus nab paclitaxel in elderly resectable/borderline resectable pancreatic adenocarcinoma. Scientific Reports. 15(1). 39597–39597.
3.
Hayashi, Yoshinori, Takuro Saito, Atsunari Kawashima, et al.. (2025). The immunosuppressive role of CCR8 + Tregs in gastric cancer. Journal of Cancer. 16(15). 4390–4399.
4.
Yamamoto, Kazuyoshi, Satoshi Hattori, Takeshi Omori, et al.. (2025). Defining Low Muscle Mass in Cancer Patients: Sex-Specific Computed Tomography-Derived Cutoff Values and Survival Impact—A Multicenter Cohort Study. Annals of Surgical Oncology. 32(12). 9014–9021.
5.
Yamada, Daisaku, Shogo Kobayashi, Yuichiro Doki, & Hidetoshi Eguchi. (2025). Genomic landscape of biliary tract cancer and corresponding targeted treatment strategies. International Journal of Clinical Oncology. 30(6). 1069–1079. 1 indexed citations
6.
Mori, Ryota, Takayuki Ogino, Mari Murakami, et al.. (2025). Group 1 innate lymphoid cells and inflammatory macrophages exacerbate fibrosis in creeping fat through IFN-γ secretion. Journal of Gastroenterology. 60(7). 838–853. 2 indexed citations
7.
Iwagami, Yoshifumi, Shogo Kobayashi, Kazuki Sasaki, et al.. (2025). Efficacy of SOAT1 Inhibitors Against Pancreatic Cancer with TP53 Mutations. Annals of Surgical Oncology. 32(9). 7025–7037.
8.
Yamamoto, Kazuyoshi, Takuro Saito, Kota Momose, et al.. (2025). 18F-fluorodeoxyglucose positron emission tomography-computed tomography as a prognostic marker of imatinib-resistant gastrointestinal stromal tumors. Surgery Today. 55(9). 1295–1302. 1 indexed citations
9.
10.
11.
Hayashi, Yoshinori, Yuji Ishii, Keiichi Yamamoto, et al.. (2024). Three-dimensional semiquantitative evaluation of reactive emphysema in magnesium implant models. Minimally Invasive Therapy & Allied Technologies. 34(2). 136–143.
12.
Kurokawa, Yukinori, Ryo Yoshioka, Tsuyoshi Takahashi, et al.. (2024). Extensive methylation analysis of circulating tumor DNA in plasma of patients with gastric cancer. Scientific Reports. 14(1). 30739–30739.
13.
Tanaka, Koji, Takeo Fujita, Yasuaki Nakajima, et al.. (2024). Validation of the cutoff values for the number of metastatic lymph nodes for esophageal cancer staging: a multi-institutional analysis of 655 patients in Japan. Esophagus. 21(4). 464–471. 1 indexed citations
14.
Momose, Kota, Kotaro Yamashita, Takuro Saito, et al.. (2024). Role of dedicated port cleaning devices in laparoscopic surgery. Surgical Endoscopy. 38(12). 7613–7620. 1 indexed citations
15.
16.
Fujishima, Yuya, Hitoshi Nishizawa, Takashi Nakamura, et al.. (2021). Increased plasma XOR activity induced by NAFLD/NASH and its possible involvement in vascular neointimal proliferation. JCI Insight. 6(17). 20 indexed citations
17.
Sekimoto, Mitsugu, Hiroaki Nagano, Yoshiyuki Fujiwara, et al.. (2011). Two Cases of Gastric Anisakiasis for which Oral Administration of a Medicine Containing Wood Creosote (Seirogan) was Effective. Hepatogastroenterology. 58(109). 1252–1254. 10 indexed citations
18.
Murakami, Masahiro, Shogo Kobayashi, Hiroaki Nagano, et al.. (2010). A difficult-to-diagnose case of hepatocellular adenoma in a septuagenarian. Kanzo. 51(1). 35–40. 1 indexed citations
19.
Doki, Yuichiro, Hiroshi Miyata, Takushi Yasuda, et al.. (2007). Four Cases of Esophageal Cancer with Nonrecurrent Inferior Laryngeal Nerve-Anatomic Variant and Intraoperative Precaution-. The Japanese Journal of Gastroenterological Surgery. 40(8). 1466–1472. 4 indexed citations
20.
Yamamoto, Makoto, Toshimasa Tsujinaka, Yuichiro Doki, et al.. (1999). Metallothionein Expression Correlates with the Pathological Response of Patients with Esophageal Cancer Undergoing Preoperative Chemoradiation Therapy. Oncology. 56(4). 332–337. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eugeniusz Wróblewski Breakdown of academic impact, for papers by Marek Winiarski Breakdown of academic impact, for papers by H N Nguyen Breakdown of academic impact, for papers by Sabrina Mellino Breakdown of academic impact, for papers by Yu‐Wen Hsu Breakdown of academic impact, for papers by Tomoe Kawamura Breakdown of academic impact, for papers by Yuko Shibuya Breakdown of academic impact, for papers by A Grisendi Breakdown of academic impact, for papers by Miguel Quesada‐Charneco Breakdown of academic impact, for papers by Wenmao Yan
Rankless by CCL
2026